DISCOUNT-OPTIONSSCHEIN - AMGEN | Real-time BOERSE MUENCHEN 03:00:02 2024-07-09 am EDT | ||
| 0.66 EUR | 0.00% |
|
| 1 month | -5.71% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-07-09 | 0.66 | 0.00% |
| 24-07-08 | 0.66 | -1.49% |
| 24-07-05 | 0.67 | -4.29% |
| 24-07-04 | 0.7 | 0.00% |
| 24-07-03 | 0.7 | +1.45% |
Real-time BOERSE MUENCHEN
Last update July 09, 2024 at 03:00 am EDT
More quotesStatic data
| Product type | Warrant Esotici e Strutturati |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HD4KBK |
| ISIN | DE000HD4KBK5 |
| Date issued | 2024-04-11 |
| Strike | 285 $ |
| Maturity | 2024-12-18 (163 Days) |
| Parity | 10 : 1 |
| Emission price | 1.29 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.3 € |
|---|---|
| Lowest since issue | 0.56 € |
| Spread | 0.1 € |
| Spread % | 14.08% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
311.5
USD
Average target price
316.4
USD
Spread / Average Target
+1.60%
- Stock Market
- Certificates
- Certificat
